Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

107.72
+1.231.16%
Pre-market: 107.56-0.1600-0.15%06:01 EDT
Volume:1.06M
Turnover:113.76M
Market Cap:12.23B
PE:31.85
High:108.53
Open:107.45
Low:106.87
Close:106.49
52wk High:109.66
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:0.69
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:85.17
PE(LYR):42.08

Loading ...

Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities